Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.
about
Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.Temporal changes in IMRT contouring of organs at risk for nasopharyngeal carcinoma - the learning curve blues and a tool that could help.Advances in the management of squamous cell carcinoma of the head and neck.Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.Co-registration of cone beam CT and planning CT in head and neck IMRT dose estimation: a feasible adaptive radiotherapy strategy.Outcome and long-term efficacy of four facio-cervical fields conformal radiotherapy for nasopharyngeal carcinomaIntensity modulated radiotherapy with concurrent chemotherapy for larynx preservation of advanced resectable hypopharyngeal cancerValue: a framework for radiation oncology.The in vivo study on the radiobiologic effect of prolonged delivery time to tumor control in C57BL mice implanted with Lewis lung cancer.Induction chemotherapy followed by radiotherapy in patients with cervical lymph node metastases from unknown primary carcinoma.Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.A new view of radiation-induced cancerProspective functional outcomes in sequential population based cohorts of stage III/ IV oropharyngeal carcinoma patients treated with 3D conformal vs. intensity modulated radiotherapy.Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptakeRandomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma.Future directions and treatment strategies for head and neck squamous cell carcinomasIntensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experienceLong-term results of ipsilateral radiotherapy for tonsil cancer.Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical resultsMulti-institutional comparison of intensity modulated radiation therapy (IMRT) planning strategies and planning results for nasopharyngeal cancer.Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck.Head and neck cancer: an evolving treatment paradigm.Controversies and challenges in the current management of nasopharyngeal cancer.Cost-effectiveness studies in radiation therapy.IMRT and IGRT in head and neck cancer: Have we delivered what we promised?Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: an evidence-based review.Clinical assessment and treatment of the dysfunctional larynx after radiation.The management of head and neck tumors with high technology radiation therapy.The potential of helical tomotherapy in the treatment of head and neck cancer.Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors.Intensity-modulated radiotherapy for head and neck surgeons.The application of the linear quadratic model to compensate the effects of prolonged fraction delivery time on a Balb/C breast adenocarcinoma tumor: An in vivo study.ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation.Objective assessment of trismus in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT).RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison.Dosimetric impact of intermediate dose calculation for optimization convergence error.Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.Doses in organs at risk during head and neck radiotherapy using IMRT and 3D-CRT.
P2860
Q30664542-E9D69AD6-6053-4492-8A9A-C5A0627B96C4Q33424719-C75721B4-A54E-4DDB-B4B4-E2F84541E2F4Q33720431-59FED019-081A-426E-9C60-37F8457F9619Q33726601-2ACCB7FB-6AE9-40D6-9753-79591A399BDEQ33782067-A4E10C95-B333-42C5-A2EA-8B2238166591Q33889375-EFB0F84C-FE9C-44E1-B3BD-F52D3B994D5DQ33933913-00A3AE29-EDE7-4B61-ACDA-52BEB815AF79Q34124269-039E754D-0CD0-46C9-8A04-C4DE20F6FA63Q34510303-CF90FD8A-BBE7-4C1E-8E42-579EE4862D8DQ34983431-C05BB90F-D21A-4A37-9A6F-C782BF52BC9DQ35019239-C5B559B9-FADE-445F-B427-9822020120D6Q35025173-DD3B494F-F3E0-4119-A1B7-75FB89524EE9Q35620377-4D80FAE7-DD1A-49BE-BCCB-A1F871853370Q35747345-2D84C0F7-D281-4235-9CA4-3352B62180DCQ36174997-4CF768C8-5343-47AB-8D5A-F144ACB61B1FQ36177257-5A4C8A5C-3B8D-49BA-AD4A-0E5C43527B4FQ36323993-FB5C1410-A4C5-4FCB-83FC-AA18A2E91266Q37015356-AAC12C29-C37A-4202-B31A-F7A6D2568F48Q37046320-2575779E-BCF5-4BF2-B5AA-042746893BA7Q37166580-87E3AF7D-683C-4612-BC7D-9AA418047527Q37245384-D32347B3-5E13-4231-8909-BB0D58D132A7Q37271937-3762A08F-19A6-4B2F-8CE1-132BE2673B7FQ37788242-4A2944CB-CD7B-45D8-936E-788EF7736F03Q37800482-ACFD8AAE-2214-4661-9E41-03A2B6849BADQ38038841-6A50C4DA-47E1-4D67-9BE7-9F9F39C2231CQ38119441-237E8DED-FC77-42B1-8D23-82A25A2DB37AQ38135214-CA198FEC-4660-45DE-A365-12640EDEF436Q38411314-E2F88C18-EFEA-4270-B63F-2491D89BF31BQ38426070-2AAAE84D-2556-49D5-B6EE-C891AC11C6CDQ38618936-E87B58B8-342F-459A-BC9A-EADF58DE8B44Q38679830-2C646CD3-7857-48B6-8EB4-02208CAE0291Q38814882-360FA4FB-53D1-45F9-86C0-32C68A4BEE8CQ38850017-8BDA704B-DF4D-4598-8D30-D4A13358005AQ38924403-D41A309B-1513-44FD-A9B5-466B6E759AD8Q39448913-DA5BBE21-10BE-48D8-8B6A-2F0B75EDA9CEQ40667453-D2CBDF3B-BBA8-4E15-8D73-BB90F8E7DB4CQ41033896-7B501BB9-0DBB-4DE9-A0FA-5DA38154C83CQ42363723-65956313-243C-417F-8729-F63F44879E1AQ42419380-CB350FE9-68A0-4D83-BE44-3734A5F89DEFQ43247292-B53A447C-FF98-42EF-8008-61AA6B40DDB0
P2860
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@ast
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@en
type
label
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@ast
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@en
prefLabel
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@ast
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@en
P2093
P356
P1476
Intensity-modulated radiothera ...... cancer: promises and pitfalls.
@en
P2093
Jatinder R Palta
Robert J Amdur
William M Mendenhall
P304
P356
10.1200/JCO.2005.04.7225
P407
P577
2006-06-01T00:00:00Z